Semaglutide and Tirzepatide with exercise for obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests two different weight-loss medications (semaglutide and tirzepatide) taken alongside exercise to help people with obesity. It aims to see which approach works better for weight loss and overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 60 years old
- Your body mass index (BMI) is between 30 and 40 (a measure of body fat based on height and weight)
- You are willing to take the medication and follow an exercise program
- You do not have serious heart, lung, or ear problems, and you are not pregnant or a smoker
- You have not had weight-loss surgery or endoscopy in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.
This trial tests a new medicine Zenagamtide to see if it helps people with excess weight lose more weight than Semaglutide, an existing weight loss drug. You may join if you are an adult with overweight or obesity but do not have diabetes.
This study tests if the medication semaglutide helps adults with overweight or obesity lose weight safely. It includes people with or without type 2 diabetes, and aims to see how well the drug works in a Bangladeshi population.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.